Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Dec 18;14(1):375.
doi: 10.1186/s13287-023-03607-x.

Comments on: "Mesenchymal stem cells transplantation for perianal fistulas: a systematic review and meta-analysis of clinical trials"

Fang Cheng  1
Affiliations
Comment

Comments on: "Mesenchymal stem cells transplantation for perianal fistulas: a systematic review and meta-analysis of clinical trials"

Fang Cheng. Stem Cell Res Ther. .

Abstract

The meta-analysis by Wang et al. (Stem Cell Res Ther 14(1):103, 2023) aims to explore whether mesenchymal stem cells are effective for perianal fistulas. The authors indicated that the difference in cell types, cell sources and cell dosages did not influence mesenchymal stem cells' efficacy, which may not be accurate. I think that local treatment with higher dosages of mesenchymal stem cells seems to not result in a higher healing rate. And, future trials should focus on donor characteristics considering past medical history of further autoimmunity, timely and cost-effective treatment to lighten the optimized therapeutic goals. In the future, it will be interesting to assess the safety and feasibility of injection of fibrin glue combined with mesenchymal stem cells in perianal fistulas.

Keywords: Mesenchymal stem cells; Perianal fistulas; Systematic review and meta-analysis.

PubMed Disclaimer

Conflict of interest statement

The author declares no competing interests.

Comment on

References

    1. Wang H, Jiang HY, Zhang YX, Jin HY, Fei BY, Jiang JL. Mesenchymal stem cells transplantation for perianal fistulas: a systematic review and meta-analysis of clinical trials. Stem Cell Res Ther. 2023;14(1):103. doi: 10.1186/s13287-023-03331-6. - DOI - PMC - PubMed
    1. Molendijk I, Bonsing BA, Roelofs H, et al. Allogeneic bone marrow-derived mesenchymal stromal cells promote healing of refractory perianal fistulas in patients with Crohn’s disease. Gastroenterology. 2015;149(4):918–927. doi: 10.1053/j.gastro.2015.06.014. - DOI - PubMed
    1. Hare JM, Fishman JE, Gerstenblith G, et al. Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial [published correction appears in JAMA. 2013 Aug 21;310(7):750. George, Richard [added]; Lardo, Albert [added]] JAMA. 2012;308(22):2369–2379. doi: 10.1001/jama.2012.25321. - DOI - PMC - PubMed
    1. Hamamoto H, Gorman JH, 3rd, Ryan LP, et al. Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage. Ann Thorac Surg. 2009;87(3):794–801. doi: 10.1016/j.athoracsur.2008.11.057. - DOI - PMC - PubMed
    1. Serena C, Keiran N, Madeira A, et al. Crohn’s disease disturbs the immune properties of human adipose-derived stem cells related to inflammasome activation. Stem Cell Rep. 2017;9(4):1109–1123. doi: 10.1016/j.stemcr.2017.07.014. - DOI - PMC - PubMed

Substances